These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21112960)

  • 1. YAP is a candidate oncogene for esophageal squamous cell carcinoma.
    Muramatsu T; Imoto I; Matsui T; Kozaki K; Haruki S; Sudol M; Shimada Y; Tsuda H; Kawano T; Inazawa J
    Carcinogenesis; 2011 Mar; 32(3):389-98. PubMed ID: 21112960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
    Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
    Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.
    Komatsu S; Imoto I; Tsuda H; Kozaki KI; Muramatsu T; Shimada Y; Aiko S; Yoshizumi Y; Ichikawa D; Otsuji E; Inazawa J
    Carcinogenesis; 2009 Jul; 30(7):1139-46. PubMed ID: 19423649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
    Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
    Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
    Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
    Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
    Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
    Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
    Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
    Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
    Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
    Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
    Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma.
    Kwon J; Lee TS; Lee HW; Kang MC; Yoon HJ; Kim JH; Park JH
    Int J Oncol; 2013 Nov; 43(5):1523-30. PubMed ID: 24042193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
    Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
    Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
    Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
    Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
    Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.